Share subscriptions based on Nanoform Finland Plc’s stock options 2/2019
Company release
Nanoform Finland Plc
October 22, 2024
19.20 Finnish time / 18.20 Swedish time
Share subscriptions based on Nanoform Finland Plc’s stock options 2/2019
A total of 1,000 Nanoform Finland Plc’s new shares has been subscribed for with the company's stock options 2/2019 on 14 October 2024. For subscriptions made with the stock options 2/2019 the entire subscription price of EUR 1,100.00 will be entered in the reserve for invested unrestricted equity. After the trade registration, the total number of shares is 85,531,236.
The shares subscribed for under the stock options 2/2019 are expected to be registered in the Trade Register on or about 31 October 2024, as of which date the new shares will establish shareholder rights.
The shares will be traded on the First North Growth Market Finland marketplace maintained by Nasdaq Helsinki Oy together with the old shares as of 1 November 2024.
For further information, please contact:
Peter Hänninen, General Counsel
+358 50 353 0408
For investor relations queries, please contact:
Henri von Haartman, Director of Investor Relations
+46 7686 650 11
About Nanoform
Nanoform is the medicine performance-enhancing company that leverages best-in-class innovative nanoparticle engineering technologies, expert formulation, and scalable GMP API manufacturing to enable superior medicines for patients. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services, from pre-formulation to commercial scale. Nanoform will help improve bioavailability and drug delivery profiles, drive differentiation, patient adherence and extend the lifecycle potential of products. Nanoform’s shares are listed on the Premier-segment of Nasdaq First North Growth Market in Helsinki (ticker: NANOFH) and Stockholm (ticker: NANOFS). Certified Adviser: Carnegie Investment Bank AB (publ), +46 8-588 68 570. For more information, please visit www.nanoform.com.